These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31094902)

  • 1. Cytochrome P450-mediated inhibition of venlafaxine metabolism by trimipramine.
    Kowalewski C; Haen E; Hiemke C; Ridders F; Endres K; Gründer G; Paulzen M; Schoretsanitis G
    Int Clin Psychopharmacol; 2019 Sep; 34(5):241-246. PubMed ID: 31094902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism.
    Paulzen M; Haen E; Hiemke C; Fay B; Unholzer S; Gründer G; Schoretsanitis G
    J Affect Disord; 2018 Feb; 227():506-511. PubMed ID: 29156365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of venlafaxine dosage, valproic acid concentration, sex, and age on steady state dose-corrected concentrations of venlafaxine and O-desmethylvenlafaxine: A retrospective analysis of therapeutic drug monitoring data in a Chinese population.
    Wang ZZ; Deng SH; Lu HY; Li L; Zhu XQ; Hu JQ; Xie HS; Chen HZ; Chen YQ; Zhang M; Fang ZY; Wen YG; Shang DW
    Hum Psychopharmacol; 2020 May; 35(3):e2733. PubMed ID: 32239743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced clearance of venlafaxine in a combined treatment with quetiapine.
    Paulzen M; Schoretsanitis G; Hiemke C; Gründer G; Haen E; Augustin M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():116-121. PubMed ID: 29702137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic correlates of venlafaxine: associated adverse reactions.
    Schoretsanitis G; Haen E; Hiemke C; Endres K; Ridders F; Veselinovic T; Gründer G; Paulzen M
    Eur Arch Psychiatry Clin Neurosci; 2019 Oct; 269(7):851-857. PubMed ID: 30923938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine.
    Kuzin M; Schoretsanitis G; Haen E; Stegmann B; Hiemke C; Gründer G; Paulzen M
    Clin Pharmacokinet; 2018 Jun; 57(6):729-737. PubMed ID: 28866861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients With Depression.
    Komahashi-Sasaki H; Yasui-Furukori N; Sasaki T; Shinozaki M; Hayashi Y; Kato K; Inoue Y; Tsuchimine S; Watanabe T; Sugawara N; Shimoda K
    Ther Drug Monit; 2021 Oct; 43(5):681-687. PubMed ID: 33306568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of antidepressant response to venlafaxine by a combination of early response assessment and therapeutic drug monitoring.
    Stamm TJ; Becker D; Sondergeld LM; Wiethoff K; Hiemke C; O'Malley G; Ricken R; Bauer M; Adli M
    Pharmacopsychiatry; 2014 Jul; 47(4-5):174-9. PubMed ID: 25054625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine Does Not Alter the Pharmacokinetics of Venlafaxine Enantiomers in Healthy Subjects Phenotyped for CYP2D6, CYP2C19, and CYP3A.
    Tozatto E; Benzi JRL; Rocha A; Coelho EB; Lanchote VL
    J Clin Pharmacol; 2021 Mar; 61(3):319-327. PubMed ID: 32974907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of venlafaxine in treatment responders and non-responders: a retrospective analysis of a large naturalistic database.
    Schoretsanitis G; Haen E; Gründer G; Hiemke C; Endres K; Ridders F; Correll CU; Paulzen M
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1109-1116. PubMed ID: 30968172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting.
    Reis M; Lundmark J; Björk H; Bengtsson F
    Ther Drug Monit; 2002 Aug; 24(4):545-53. PubMed ID: 12142641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the pharmacokinetic interaction between ticagrelor and venlafaxine, a cytochrome P-450 2D6 substrate, in healthy subjects.
    Teng R; Kujacic M; Hsia J
    Clin Ther; 2014 Sep; 36(9):1217-25. PubMed ID: 25069798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 and CYP2C19 Polymorphisms.
    Shen C; Yang H; Shao W; Zheng L; Zhang W; Xie H; Jiang X; Wang L
    Pharm Res; 2024 Apr; 41(4):731-749. PubMed ID: 38443631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex and body weight are major determinants of venlafaxine pharmacokinetics.
    Schoretsanitis G; Haen E; Hiemke C; Fay B; Unholzer S; Correll CU; Gründer G; Paulzen M
    Int Clin Psychopharmacol; 2018 Nov; 33(6):322-329. PubMed ID: 30028351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of venlafaxine, O-desmethylvenlafaxine, and O-desmethylvenlafaxine to venlafaxine ratio in postmortem human brain tissue.
    Murrell MD; Cruz DA; Javors MA; Thompson PM
    J Forensic Sci; 2014 May; 59(3):683-9. PubMed ID: 24502274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to Treat Hypertension in Venlafaxine-Medicated Patients-Pharmacokinetic Considerations in Prescribing Amlodipine and Ramipril.
    Augustin M; Schoretsanitis G; Gründer G; Haen E; Paulzen M
    J Clin Psychopharmacol; 2018 Oct; 38(5):498-501. PubMed ID: 30102628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective solid-phase extraction using molecularly imprinted polymers for analysis of venlafaxine, O-desmethylvenlafaxine, and N-desmethylvenlafaxine in plasma samples by liquid chromatography-tandem mass spectrometry.
    Miranda LF; Domingues DS; Queiroz ME
    J Chromatogr A; 2016 Aug; 1458():46-53. PubMed ID: 27388659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes--focus on venlafaxine and O-desmethylvenlafaxine.
    Kandasamy M; Srinivas P; Subramaniam K; Ravi S; John J; Shekar R; Srinivas N; Thangam S
    Eur J Clin Pharmacol; 2010 Sep; 66(9):879-87. PubMed ID: 20446083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood.
    Kingbäck M; Karlsson L; Zackrisson AL; Carlsson B; Josefsson M; Bengtsson F; Ahlner J; Kugelberg FC
    Forensic Sci Int; 2012 Jan; 214(1-3):124-34. PubMed ID: 21840145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
    Pandey A; Price A; Ayala-Lopez N; Garza KY; Marzinke MA; Knezevic CE
    J Pharm Biomed Anal; 2024 Jun; 243():116082. PubMed ID: 38461636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.